Oncology Central

NCRI 2018: HiLo trial suggests low risk thyroid cancer patients can receive lower doses of radiation

Presenting the HiLo trial results at the 2018 NCRI Cancer Conference (4–6 November 2018, Glasgow, Scotland) Jonathan Wadsley (Weston Park Hospital, Sheffield, UK) reported no significant difference in the recurrence rate between thyroid cancer patients given a low radiation dose compared to the standard higher dose.
Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.